Loading...
•
Dec 31, 2025
Select Medical Q4 2025 Earnings Report
Select Medical reported higher fourth quarter 2025 revenue and a return to profitability from continuing operations, while Adjusted EBITDA declined year over year.
Key Takeaways
For Q4 2025, Select Medical generated revenue of 1396634000, up 6.4% year over year. Income from continuing operations, net of tax, was 37742000, compared to a loss in the prior year period. Diluted EPS from continuing operations was 0.16 and Adjusted EBITDA was 104664000.
Revenue increased 6.4% year over year to 1396634000.
Income from continuing operations, net of tax, was 37742000 versus a prior year loss.
Diluted EPS from continuing operations was 0.16.
Adjusted EBITDA totaled 104664000 for the quarter.
Revenue by Segment
Forward Guidance
For 2026, Select Medical expects revenue between 5600000000 and 5800000000, Adjusted EBITDA between 520000000 and 540000000, and fully diluted earnings per share between 1.22 and 1.32.
Positive Outlook
- Revenue expected between 5600000000 and 5800000000.
- Adjusted EBITDA expected between 520000000 and 540000000.
- Fully diluted EPS expected between 1.22 and 1.32.
- Continued growth in rehabilitation hospital segment.
- Stable interest expense outlook for 2026.
Challenges Ahead
- Ongoing reimbursement and regulatory risks.
- Labor shortages may increase operating costs.
- Exposure to inflationary pressures.
- Potential impacts from government investigations or policy changes.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...